Rua Bioscience Ltd. has appointed experienced global pharmaceutical executive Dr. Andrea Grant as Chief Commercial Officer (CCO). Dr. Grant will drive the medicinal cannabis company's domestic and global commercialisation and business development strategy. Dr. Grant's first priority will be to lead Rua's global expansion into key markets. She brings 20 years of business development experience in the pharmaceutical and biotech industries globally. Dr. Grant comes to Rua from Janssen Cilag Pty NZ (the pharmaceutical business of Johnson & Johnson), where she was the Market Access Manager responsible for commercializing innovative medicines to NZ patients.